Impact of haloperidol and risperidone on gene expression profile in the rat cortex

Liliána Z. Fehér, János Kálmán, László G. Puskás, Gábor Gyülvészi, Klára Kitajka, Botond Penke, Miklós Palotás, Elena I. Samarova, József Molnár, Ágnes Zvara, Keyvan Matin, Nikoletta Bódi, Marietta Hugyecz, Magdolna Pákáski, Annamária Bjelik, Anna Juhász, Gábor Bogáts, Zoltán Janka, András Palotás

Research output: Contribution to journalArticle

39 Citations (Scopus)


Despite the clinical efficacy of the most thoroughly studied conventional neuroleptic agent haloperidol, and the atypical antipsychotic risperidone is well established, little information is available on their molecular effects. Recent advances in high-density DNA microarray techniques allow the possibility to analyze thousands of genes simultaneously for their differential gene expression patterns in various biological processes, and to determine mechanisms of drug action. The aim of this series of experiments was to gain experience in antipsychotic gene-expression profiling and characterize (in the parlance of genomics) the "antipsychotic transcriptome." In this prospective animal study, broad-scale gene expression profiles were characterized for brains of rats treated with antipsychotics and compared with those of sham controls. We used DNA microarrays containing 8000 sequences to measure the expression patterns of multiple genes in rat fronto-temporo-parietal cortex after intraperitoneal treatment with haloperidol or risperidone. A number of transcripts were differentially expressed between control and treated samples, of which only 36 and 89 were found to significantly differ in expression as a result of exposure to haloperidol or risperidone, respectively (P < 0.05). Acutely, 13 genes were more highly expressed and 15 transcripts were found to be significantly less abundant, whereas chronically nine genes were up-regulated and none of them was repressed in haloperidol-treated cortices. Risperidone acutely induced 43 and repressed 46 genes, and chronically over-expressed 6 and down-regulated 11 transcripts. Selected genes were assayed by real-time PCR, then normalized to β-actin. These assays confirmed the significance of the array results for all transcripts tested. Despite their differing receptor affinity and selectivity, our findings indicate that haloperidol and risperidone interfere with cell survival, neural plasticity, signal transduction, ionic homeostasis and metabolism in a similar manner.

Original languageEnglish
Pages (from-to)271-280
Number of pages10
JournalNeurochemistry international
Issue number4
Publication statusPublished - Sep 1 2005



  • Antipsychotic
  • Calcium
  • Gene expression
  • Haloperidol
  • Microarray
  • Neurodegenerative disease
  • Neuronal plasticity
  • Risperidone

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Cell Biology

Cite this